Subclinical hypothyroidism and plasma levels of commonly prescribed anti-seizure medications

Anusha Natarajan; R. Priyadharsini; Suja Xaviar; Ramkumar Sugumaran

doi:10.18203/2319-2003.ijbcp20243035

Authors

Anusha Natarajan Department of Pharmacology, JIPMER, Pondicherry, India
R. Priyadharsini Department of Pharmacology, JIPMER, Pondicherry, India
Suja Xaviar Department of Pharmacology, ESIC Medical College and Hospital, Chennai, Tamil Nadu, India
Ramkumar Sugumaran Department of Neurology, JIPMER, Pondicherry, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20243035

Keywords:

Antiepileptics, Subclinical hypothyroidism, Plasma levels, TDM

Abstract

Background: Epilepsy remains the most common neurological problem worldwide. Most commonly prescribed antiseizure medications (ASMs) like phenytoin, sodium valproate, and carbamazepine show high inter-individual variability in bioavailability due to genetic and epigenetic factors resulting in either therapeutic failure or toxicity. In our study, we aim to determine the association between subclinical hypothyroidism and the plasma levels of these commonly prescribed ASMs, leading to either therapeutic failure or adverse drug reactions.

Methods: We collected demographic data, details about the antiepileptic medication, and plasma levels of ASMs (phenytoin, carbamazepine, and sodium valproate) from patients on antiseizure medications who came for routine therapeutic drug monitoring (TDM). High-performance liquid chromatography (HPLC) estimated plasma levels of the antiseizure medications as per the TDM laboratory standard operating procedure (SOP) and thyroid function test (TSH) by a standard enzyme-linked immune-sorbent assay (ELISA) kit.

Results: Of the 158 patients who had TDM, 75.31% were taking sodium valproate, 15.18% were on phenytoin, and 9.49% were on carbamazepine monotherapy. In our study, we found that 12 patients (7.59%) had TSH levels between 4 to 10 mIU/l, indicating subclinical hypothyroidism (SCH). The plasma drug levels of all 12 patients who had SCH were found to be below the therapeutic range.

Conclusions: This study has established a significant association between ASMs, particularly sodium valproate, and thyroid dysfunction, specifically SCH, in patients with epilepsy. Our findings suggest that prolonged ASM therapy can lead to thyroid disturbances, warranting careful monitoring of thyroid function in these patients.

Metrics

Metrics Loading ...

References

Hamed SA. The effect of antiseizure medications on thyroid hormonal function: causes and implications. Expert Rev Clin Pharmacol. 2015;8(6):741-50.

Deshmukh V, Behl A, Iyer V, Joshi H, Dholye JP, Varthakavi PK. Prevalence, clinical and biochemical profile of subclinical hypothyroidism in normal population in Mumbai. Indian J Endocr Metab. 2013;17:454-9.

Hamed SA. Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions. Epilepsy Res. 2007;75(1):1-9.

Tanaka K, Kodama S, Yokoyama S, Komatsu M, Konishi H, Momota K, et al. Thyroid function in children with long-term anticonvulsant treatment. Pediatr Neurosci. 1987;13(2):90-4.

Eiris-Punal J, Del Rio-Garma M, Del Rio-Garma MC, Lojo-Rocamonde S, Novo-Rodríguez I, Castro-Gago M. Long-term treatment of children with epilepsy with valproate or carbamazepine may causesubclinical hypo- thyroidism. Epilepsia. 1999;40(12):1761-6.

Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT, et al. Subclinical thyroid dysfunction: a joint state- ment on management from theAmerican Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Endocr Pract. 2004;10(6):497-501.

Gardun o-GarciaJde J, Alvirde-Garcia U, Lopez-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010;163(2):273-8.

Sarich TC, Wright JM. Hypothyroxinemia and phenytoin toxicity: a vicious circle. Drug Metabol Drug Interact. 1996;13(2):155-60.

Lai EC-C, Yang Y-HK, Lin S-J, Hsieh C-Y. Use of antiseizure medications and risk of hypothyroidism: antiseizure medications and hypothyroidism. Pharmaco-epidemiol Drug Safety. 2013;22(10):1071-9.

Larkin JG, Macphee GJ, Beastall GH, Brodie MJ. Thyroid hormone concentrations in epileptic patients. Eur J Clin Pharmacol. 1989;36(3):213-6.

Connacher AA, Borsey DQ, Browning MC, Davidson DL, Jung RT. The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic. Postgrad Med J. 1987;63(744):841-5.

Bergqvist N, Mare O. Hypothyroidism and Cerebral Edema Following Combined Treatment of Tuberculosis with Conteben (TB I 698) and p-Amino-Salicylic Acid. Acta Medica Scandinavica. 1952;143(5):323-35.

James WD, Berger T, Elston D. Andrews' Diseases of the skin clinical dermatology (11th edition). [London]: Saunders/ Elsevier. 2011.

Elshorbagy HH, Barseem NF, Suliman HA, Talaat E, Alshokary AH, Abdelghani WE, et al. The Impact of Antiseizure medications on Thyroid Function in Children with Epilepsy: New Versus Old. Iran J Child Neurol. 2020;14(1):31-41.

Benedetti MS, Whomsley R, Baltes E, Tonner F. Alteration of thyroid hormone homeostasis by antiseizure medications in humans: involvement of glucuronosyltransferase induction. Eur J Clin Pharmacol. 2005;61(12):863-72.

Kim SH, Chung HR, Kim SH, Kim H, Lim BC, Chae JH, et al. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy. Neuropediatrics. 2012;43(3):135-9.